Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company
Hoffmann-La Roche
AstraZeneca
Varian, a Siemens Healthineers Company
AstraZeneca
Seagen Inc.
Seagen Inc.
Target PharmaSolutions, Inc.
Astellas Pharma Inc
Hoffmann-La Roche
Idience Co., Ltd.
Jazz Pharmaceuticals
Sichuan Baili Pharmaceutical Co., Ltd.
Bristol-Myers Squibb
MOMA Therapeutics
Cogent Biosciences, Inc.
Eli Lilly and Company
Hoffmann-La Roche
AstraZeneca
Novartis
Boehringer Ingelheim
Novartis
Takeda
Edwards Lifesciences
Astellas Pharma Inc
Eli Lilly and Company
Coherus Oncology, Inc.
AstraZeneca
OncoC4, Inc.
Taiho Oncology, Inc.
Genmab
Revolution Medicines, Inc.
USWM, LLC (dba US WorldMeds)
Pfizer
AstraZeneca
Seagen Inc.
Pfizer
Regeneron Pharmaceuticals
Bristol-Myers Squibb
Ferronova Pty Ltd
Astellas Pharma Inc
Actuate Therapeutics Inc.
Servier
Bristol-Myers Squibb
Arcus Biosciences, Inc.
Novartis
Boehringer Ingelheim
Arcus Biosciences, Inc.
Arcus Biosciences, Inc.